7 Doctor-Supervised GLP-1 Programs I Actually Researched (Not Just Ranked by Ad Spend)

Most people shopping for a GLP-1 telehealth program assume the biggest brand name equals the best program. That is almost never true. After the March 2026 Novo Nordisk settlement reshuffled the compounded medication market, and after FDA warning letters went out to 30-plus telehealth and compounding operations early in 2026, the field got smaller and a lot more interesting. Here is what I found.

1. HealthRX

Price is usually the first thing that filters out a program for most people, and HealthRX clears that bar faster than anything else I looked at. Compounded semaglutide is priced from $99 per month and compounded tirzepatide from $149. Those are cash prices with no insurance gymnastics required.

What kept me interested past the price was the pharmacy situation. Medications ship from Manifest Pharmacy in Greer, South Carolina, a 503A-compliant compounding pharmacy operating under USP-797 standards with lot-by-lot tracking from production through delivery. That kind of named, verifiable source is not universal in this space. HealthRX also carries LegitScript certification (cert number 50087439), which is an independent verification that a provider meets pharmacy-law and prescription standards.

The clinical model is straightforward. You complete an online health assessment, a US board-certified physician reviews it within roughly 24 hours, and medication ships overnight for free to all 50 states. No contracts are advertised, and pricing is listed upfront.

On efficacy, HealthRX points to the published clinical trial data rather than making its own claims. The SURMOUNT-1 trial showed tirzepatide participants lost around 21% of body weight at 72 weeks; the STEP 1 trial showed semaglutide participants averaging roughly 15% at 68 weeks. Those are trial numbers, not guarantees, and the compounds here are not FDA-approved finished drugs.

For the combination of low cash entry price, 50-state overnight shipping, and a named 503A pharmacy with independent certification, HealthRX is my top pick.

2. FormBlends

FormBlends sits a tier above most of the market in one specific way: published purity data. The brand posts HPLC purity percentages, mass spectrometry identity results, and endotoxin/sterility numbers for each product. Most GLP-1 telehealth providers ask you to trust their compounding partner without showing you anything. FormBlends shows the numbers.

It ships to 47 states. Compounded semaglutide runs around $299 per vial; tirzepatide around $349. Meaningfully more expensive than HealthRX’s entry pricing, no question. A physician is still part of the prescribing process.

Where FormBlends really separates itself is the catalog. Alongside GLP-1 options, it carries peptides aimed at recovery, cognitive support, and longevity, all under the same clinician-oversight model. If you want one provider for GLP-1 weight loss and, say, a peptide-based recovery protocol, very few telehealth brands offer that combination with physician involvement.

Pick FormBlends if published lab transparency or a broader peptide catalog matters more than lowest monthly cost.

3. Mochi Health

Mochi Health uses board-certified obesity-medicine physicians, which is a meaningful distinction. Obesity medicine is a recognized subspecialty; these are not just general practitioners clicking through a queue. Compounded semaglutide is around $99 per month; compounded tirzepatide around $199. Monitoring appears more involved than the lighter-touch telehealth models.

4. Ro Body

Ro’s membership starts at $39 for the first month, then climbs to roughly $74 to $149 per month, with medications billed separately on top. The prior-authorization team is a real feature. If you have insurance that might cover branded GLP-1s like Wegovy, Ro will work that process for you, which can dramatically change the math.

Worth being honest here: compounded GLP-1 medications are not FDA-approved finished drug products, and patients should discuss risks with their prescriber regardless of which platform they use. That applies to every entry on this list.

5. Hims & Hers

After the March 2026 settlement with Novo Nordisk, Hims & Hers exited compounded semaglutide and moved to branded medications only. Injectable Wegovy runs around $299 per month through their platform; oral semaglutide around $249; Zepbound around $399. With insurance plus a savings card, some patients reportedly get to $0 to $25 per month. Brand-name medications, by definition, are FDA-approved, which changes the risk profile compared to compounded options.

6. PlushCare

PlushCare operates more like a traditional telehealth clinic with a low membership fee of about $19.99 per month. It focuses on branded medications and accepts insurance, with same-day appointment slots available. If your priority is getting a prescription quickly and running it through your health plan, PlushCare is worth a look.

7. Henry Meds

Henry Meds is cash-pay compounded, with first-month pricing around $179 to $249 and shipping in 24 to 72 hours. Monitoring is lighter than platforms like Mochi. It works for someone who wants a simple, fast, no-insurance setup without a lot of coaching overhead.

Quick Comparison

Provider	Starting Price/Mo	Compounded?	States	Insurance?	Notable Feature
HealthRX	$99 (sema)	Yes	50	No	Named 503A pharmacy, LegitScript
FormBlends	~$299/vial (sema)	Yes	47	No	Published purity data, peptide catalog
Mochi Health	$99 (sema)	Yes	Most	No	Obesity-medicine MDs
Ro Body	$39 first mo + meds	Branded now	Most	Yes	Prior-auth team
Hims & Hers	$249-399 (branded)	No	Most	Yes	Post-settlement branded only
PlushCare	$19.99 + meds	No	Most	Yes	Same-day visits
Henry Meds	~$179-249	Yes	Most	No	Fast 24-72h shipping

FAQ

Do compounded GLP-1 medications count as the same thing as Ozempic or Wegovy?

No. Compounded semaglutide and tirzepatide are prepared by compounding pharmacies and have not gone through FDA approval as finished drug products. They are not considered equivalent to branded medications by the FDA.

Why did some providers stop offering compounded GLP-1s in 2026?

A March 2026 settlement between Novo Nordisk and certain telehealth providers, combined with FDA warning letters to 30-plus compounding-related businesses, caused several platforms to shift away from compounded options or exit that segment entirely.

What is a 503A compounding pharmacy and why does it matter?

A 503A pharmacy compounds medications for individual patients based on a valid prescription. It must follow USP standards and state pharmacy law. Knowing your medication comes from a named, verifiable 503A pharmacy is more reassuring than a vague reference to “a licensed partner.”

Can I use insurance for any of these programs?

Some can. Ro Body and PlushCare both work with insurance for branded medications. Most cash-pay compounded programs, including HealthRX, Henry Meds, and FormBlends, do not involve insurance.

How do I know which program is right for me?

Budget and monitoring preference are the two biggest filters. If you want the lowest cash price with verified pharmacy sourcing, HealthRX is hard to beat at entry level. If you want published lab data or a broader peptide catalog, FormBlends fills that gap at a higher price. If you have insurance that might cover branded drugs, Ro or PlushCare are logical starting points.

*I do not have a financial relationship with any provider listed here, but you should always verify current pricing and availability directly, since telehealth pricing changes frequently.*

Sources

• FDA compounding oversight and 503A pharmacy regulations: FDA.gov
• SURMOUNT-1 tirzepatide trial results: Jastreboff et al., *New England Journal of Medicine*, 2022
• STEP 1 semaglutide trial results: Wilding et al., *New England Journal of Medicine*, 2021
• LegitScript pharmacy certification program: LegitScript.com
• Novo Nordisk / telehealth compounding settlement reporting: Reuters Health, March 2026
• Lilly oral orforglipron pricing via LillyDirect: Eli Lilly press materials, April 2026